Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for LFST

Stock NameLifestance Health Group Inc
TickerLFST(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS53228F1012

Show aggregate LFST holdings

News associated with LFST

LifeStance Health Group (NASDAQ:LFST) vs. DaVita (NYSE:DVA) Financial Review
LifeStance Health Group (NASDAQ:LFST – Get Free Report) and DaVita (NYSE:DVA – Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Institutional and Insider Ownership 85.5% of LifeStance […] - 2025-09-11 02:15:15
Victory Capital Management Inc. Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST)
Victory Capital Management Inc. grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 2,599.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 370,598 shares of the company’s stock after acquiring an additional 356,867 shares during the quarter. […] - 2025-07-29 04:22:52
BTIG Research Initiates Coverage on LifeStance Health Group (NASDAQ:LFST)
BTIG Research started coverage on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued a buy rating and a $8.00 price target on the stock. A number of other equities analysts also recently commented on the stock. KeyCorp began coverage on shares of LifeStance […] - 2025-07-28 04:22:50
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.50 Consensus Price Target from Brokerages
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating […] - 2025-07-17 04:40:51
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Sold by Principal Financial Group Inc.
Principal Financial Group Inc. cut its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,584,850 shares of the company’s stock after selling 203,856 shares during the period. Principal […] - 2025-07-09 05:51:37
Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.50
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the […] - 2025-06-20 02:20:16
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 16.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 604,321 shares of the company’s stock […] - 2025-06-04 05:02:51
LifeStance Health Group (NASDAQ:LFST) Raised to Buy at UBS Group
LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.50 target price on the stock. UBS Group’s target price suggests a potential upside of 40.73% from the […] - 2025-05-29 02:30:55
61,247 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Bought by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. purchased a new position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund purchased 61,247 shares of the company’s stock, valued at approximately $451,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the […] - 2025-05-27 04:34:49
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has […] - 2025-05-26 02:48:50
BNP Paribas Financial Markets Takes Position in LifeStance Health Group, Inc. (NASDAQ:LFST)
BNP Paribas Financial Markets purchased a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 118,842 shares of the company’s stock, valued at approximately $876,000. A number of other hedge funds and other institutional investors have also recently made changes to […] - 2025-05-22 04:38:48
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Invesco Ltd.
Invesco Ltd. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 30.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 162,146 shares of the company’s stock after acquiring an additional 37,718 shares during the quarter. Invesco Ltd.’s holdings in LifeStance Health Group were worth $1,195,000 as of its […] - 2025-05-02 04:15:05
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30
Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a […] - 2025-05-01 02:50:47
Legal & General Group Plc Boosts Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)
Legal & General Group Plc lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,557 shares of the company’s stock after purchasing an additional 5,917 shares during the […] - 2025-04-28 04:55:10
Renaissance Technologies LLC Acquires 495,300 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)
Renaissance Technologies LLC lifted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 421.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 612,800 shares of the company’s stock after acquiring an additional 495,300 shares during the period. Renaissance […] - 2025-04-22 05:02:58
Geode Capital Management LLC Raises Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)
Geode Capital Management LLC lifted its position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,465,471 shares of the company’s stock after acquiring an additional 13,293 shares during the […] - 2025-04-18 04:34:52
LifeStance Health Group, Inc. (NASDAQ:LFST) Holdings Raised by Wellington Management Group LLP
Wellington Management Group LLP increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 9.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,276,237 shares of the company’s stock after purchasing an additional 445,796 shares during the quarter. Wellington […] - 2025-04-07 05:26:56
13,053 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by Cibc World Markets Corp
Cibc World Markets Corp purchased a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 13,053 shares of the company’s stock, valued at approximately $96,000. A number of other large investors […] - 2025-03-28 06:16:49
Keybank National Association OH Has $420,000 Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)
Keybank National Association OH grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 86.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,974 shares of the company’s stock after buying an additional 26,412 shares during […] - 2025-03-10 05:53:03
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Rhumbline Advisers
Rhumbline Advisers increased its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 195,581 shares of the company’s stock after acquiring an additional 8,487 shares during […] - 2025-03-05 07:04:57
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.70 Consensus Target Price from Analysts
Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy […] - 2025-03-05 04:40:45

iShares MSCI World Small Cap UCITS ETF USD (Acc) LFST holdings

DateNumber of LFST Shares HeldBase Market Value of LFST SharesLocal Market Value of LFST SharesChange in LFST Shares HeldChange in LFST Base ValueCurrent Price per LFST Share HeldPrevious Price per LFST Share Held
2025-10-15 (Wednesday)109,254USD 567,028USD 567,028
2025-10-10 (Friday)108,546USD 548,157USD 548,157
2025-10-08 (Wednesday)108,546USD 612,199USD 612,199
2025-10-07 (Tuesday)108,546LFST holding increased by 470USD 600,259LFST holding decreased by -6047USD 600,259470USD -6,047 USD 5.53 USD 5.61
2025-10-06 (Monday)108,076USD 606,306LFST holding increased by 10807USD 606,3060USD 10,807 USD 5.61 USD 5.51
2025-10-03 (Friday)108,076USD 595,499LFST holding increased by 17292USD 595,4990USD 17,292 USD 5.51 USD 5.35
2025-10-02 (Thursday)108,076USD 578,207LFST holding decreased by -10807USD 578,2070USD -10,807 USD 5.35 USD 5.45
2025-10-01 (Wednesday)108,076USD 589,014LFST holding decreased by -5404USD 589,0140USD -5,404 USD 5.45 USD 5.5
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LFST by Blackrock for IE00BF4RFH31

Show aggregate share trades of LFST

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY470 5.530* 6.45
2025-09-08SELL-936 5.610* 6.52 Profit of 6,099 on sale
2025-08-15BUY466 5.440* 6.52
2025-07-14BUY948 4.570* 6.65
2025-06-30BUY940 5.170* 6.76
2025-06-25BUY1,404 4.950* 6.79
2025-06-20SELL-238 4.830* 6.83 Profit of 1,626 on sale
2025-06-12SELL-1,888 5.420* 6.93 Profit of 13,075 on sale
2025-06-02BUY708 5.880* 7.01
2025-05-28BUY472 6.040* 7.04
2025-05-14BUY233 5.740* 7.18
2025-05-13BUY466 5.870* 7.20
2025-05-07BUY696 5.510* 7.27
2025-04-28BUY230 6.530* 7.32
2025-04-16BUY3,003 6.710* 7.42
2025-04-14BUY458 6.850* 7.44
2025-04-08SELL-462 6.530* 7.48 Profit of 3,455 on sale
2025-04-04SELL-472 6.640* 7.51 Profit of 3,544 on sale
2025-03-28BUY2,330 6.700* 7.57
2025-03-12SELL-464 6.850* 7.76 Profit of 3,600 on sale
2025-03-04SELL-462 8.020* 7.78 Profit of 3,595 on sale
2025-02-26SELL-924 7.510* 7.79 Profit of 7,194 on sale
2025-02-13BUY235 7.990* 7.77
2025-02-12BUY936 7.860* 7.76
2025-01-27BUY231 8.000* 7.56
2025-01-23BUY231 7.990* 7.50
2024-12-09BUY8,496 7.430* 7.44
2024-12-04BUY468 7.330* 7.50
2024-12-03BUY702 7.460* 7.51
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LFST

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19317,6920562,55256.5%
2025-09-18266,9160826,13332.3%
2025-09-1772,6350422,08217.2%
2025-09-1682,0210457,52717.9%
2025-09-15443,66301,023,74443.3%
2025-09-12126,649401321,54739.4%
2025-09-11171,6430461,79737.2%
2025-09-10405,647100950,37542.7%
2025-09-09306,02001,019,57130.0%
2025-09-08681,09101,229,28555.4%
2025-09-05189,372216412,64745.9%
2025-09-04269,89949,615563,77747.9%
2025-09-03389,6640849,17945.9%
2025-09-02370,9490721,56951.4%
2025-08-29380,7430783,84048.6%
2025-08-28169,2280447,02237.9%
2025-08-27365,6870935,39239.1%
2025-08-26256,07250486,24352.7%
2025-08-25372,7860696,44453.5%
2025-08-22450,06011,117,29340.3%
2025-08-21646,46501,452,98944.5%
2025-08-20168,2010941,10317.9%
2025-08-19279,5361001,252,58922.3%
2025-08-18200,716578591,68533.9%
2025-08-15399,40611,517899,52844.4%
2025-08-14962,034122,354,26740.9%
2025-08-13920,6235,8802,748,77133.5%
2025-08-12208,84201,208,71817.3%
2025-08-11282,56201,883,46015.0%
2025-08-08382,0014,6112,932,91213.0%
2025-08-07305,2681,9701,764,26617.3%
2025-08-06218,8020653,85433.5%
2025-08-05292,7500697,09242.0%
2025-08-04633,5590992,73963.8%
2025-08-01590,3370917,72764.3%
2025-07-31470,7760942,73049.9%
2025-07-30427,4950927,47146.1%
2025-07-29316,9470959,99633.0%
2025-07-28338,0920670,59450.4%
2025-07-25354,00715683,61451.8%
2025-07-24399,6540799,37650.0%
2025-07-23380,5365,500952,83939.9%
2025-07-22302,49402,026,19914.9%
2025-07-21306,32111,713882,23834.7%
2025-07-18280,3964,666875,42932.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.